WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

High Return Rate: Are Chinese Innovative Drugs Facing a "Breakup" Crisis in Ov... Analysis of Booming License-Out Deals Reveals a Concerning Trend of Terminated Collaborations for Chinese Pharmaceutical Companies, according to a recent feature article ...
(4/29/2025)

'China's Ozempic' may vie with Eli Lilly, Novo... (5/20/2025)

How Trump's Proposed Price Cuts Could Hurt Chi... (5/20/2025)

US Tariffs on Pharmaceuticals Could Hit Chines... (5/16/2025)

SMEI: China's Pharmaceutical Industry Seeks St... (5/16/2025)

Trump's Drug Pricing and the US-China Trade De... (5/12/2025)

China Still Go-To Source for New Drugs Despite... (5/9/2025)

Redefining Translational Research and China's ... (5/8/2025)

China Introduces A New Regulatory Data Protect... (5/5/2025)

Pharma's Crossroads: U.S. Investment Surges Un... (5/1/2025)

High Return Rate: Are Chinese Innovative Drugs... (4/29/2025)

China Aims for Significant Pharma Industry Dig... (4/26/2025)

MNC Pharma's Q1/2025 China Performance: Diverg... (4/25/2025)

CSPC Pharma's JMT106 Approved for Clinic... (5/20/2025) CDE Seeks Feedback on Draft Guidelines f... (5/20/2025) CDE Solicits Feedback on Draft Guideline... (5/20/2025) CDE Seeks Comments on Draft Guideline fo... (5/20/2025) CDE Solicits Comments on the 94th Batch ... (5/20/2025) Innovent's XNW5004 Receives Breakthrough... (5/20/2025) CTTQ Initiates Phase 3 Trial of HER2-Tar... (5/20/2025) 3SBio Advances SSGJ-707 into Phase 3 Tri... (5/20/2025) ArkBio Announces Positive Phase II Resul... (5/20/2025) SparX and Mitsubishi Tanabe Forge Strate... (5/20/2025) BeiGene Advances BTK Degrader BGB-16673 ... (5/20/2025) WuXi Bio Transfers Leverkusen Facility t... (5/20/2025) JHM Secures Strategic Investment to Adva... (5/20/2025) Nuance Reports Positive Top-Line Results... (5/20/2025) Evive Bio Partners with LENIS Farma to E... (5/20/2025) Pfizer Enters into $6B Exclusive Licensi... (5/20/2025) WuXi Biologics Offloads German Plant to ... (5/16/2025) Viva Biotech Unveils Proprietary AI Plat... (5/16/2025)

China's Hospital Drug Market Shows Slight Growth in 202... China Unveils Ambitious Plan to Boost Health-Related Co... Chinese VMS OTC Market Growth Slowed to 2.7% in 2024 Newish Tech Secures Series B Financing to Advance Next-... China's Retail Pharmacy Market Reaches CNY 574 Billion ...

Pfizer Enters into $6B Exclusive Licensing Agreement wi... Evive Bio Partners with LENIS Farma to Expand Ryzneuta... JHM Secures Strategic Investment to Advance Synthetic B... WuXi Bio Transfers Leverkusen Facility to Terumo in €1... SparX and Mitsubishi Tanabe Forge Strategic ADC Researc...

CDE Solicits Comments on the 94th Batch of Reference Fo... CDE Seeks Comments on Draft Guideline for Age-Friendly ... CDE Solicits Feedback on Draft Guidelines for Writing E... CDE Seeks Feedback on Draft Guidelines for Designing Cl... NMPA Orders Package Insert/Label Update for Ranitidine ...

China Expands Geriatric Services at Major Hospitals as ... China's BMI Fund Reports Big Surplus in Q1/2025 China's Public Hospitals Grapple with Mounting Debt Ami... Dementia Cases Surge in China at an Unprecedented Rate NHC Ministers Meet with Top Pharma MNC Executives

AstraZeneca Faces Escalating Legal Challenges in China ... BeiGene Secures Key Patent Victory in Brukinsa Dispute ... State Council Approves Draft Medical Security Law, Stre... Novo Nordisk Sues KBP Biosciences for $830 Million Over... State Council Releases Final Antitrust Guidelines for t...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

Nuance Reports Positive Top-Line Results from Phase 3 T... BeiGene Advances BTK Degrader BGB-16673 in Head-to-Head... ArkBio Announces Positive Phase II Results of AK3280 3SBio Advances SSGJ-707 into Phase 3 Trial for NSCLC Innovent's XNW5004 Receives Breakthrough Therapy Design...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...